Macro Electronics Corp. v. Biotech Restorations of Florida LLC

CourtDistrict Court, M.D. Florida
DecidedSeptember 16, 2024
Docket8:24-cv-01296
StatusUnknown

This text of Macro Electronics Corp. v. Biotech Restorations of Florida LLC (Macro Electronics Corp. v. Biotech Restorations of Florida LLC) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Macro Electronics Corp. v. Biotech Restorations of Florida LLC, (M.D. Fla. 2024).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF FLORIDA TAMPA DIVISION

MACRO ELECTRONICS CORP. and STEVEN P. APELMAN,

Plaintiffs, v. Case No. 8:24-cv-01296-WFJ-SPF

BIOTECH RESTORATIONS OF FLORIDA LLC

Defendant. _________________________________/

ORDER Upon due and careful consideration of Defendant’s Motion to Dismiss Plaintiffs’ First Amended Complaint, Dkt. 28, and Plaintiffs’ Response in Opposition, Dkt. 29, the Court concludes that the First Amended Complaint (the “Amended Complaint”) is sufficient to withstand dismissal. I. BACKGROUND Plaintiffs Macro Electronics Corp. and Steven P. Apelman (the “Plaintiffs”) bring this action seeking to void alleged fraudulent transfers made by Christopher Young (“Young”) to Biotech Restorations of Florida, LLC, (“Biotech 2” or the “Defendant”) in violation of Florida’s Uniform Fraudulent Transfer Act (“FUFTA”), Chapter 726, Florida Statutes. Dkt. 1. On July 9, 2024, this Court dismissed Plaintiffs’ original complaint, Dkt. 1, without prejudice for failure to state a claim. Dkt. 26. In an Endorsed Order, the Court directed Plaintiffs to do the following:

The Plaintiff should cite to the applicable Florida procedural statute in any amended complaint, including setting forth the elements thereunder. What was conveyed fraudulently must be alleged. Remedy is available, of course, not for the amount of the underlying judgment but for the amount that the Plaintiff can prove was fraudulently conveyed in defeat of creditors. If Plaintiff seeks to replead, Plaintiff would do well to review case law on these points such as those arising under Florida Stat. Chap. 726. Likewise, if Plaintiff seeks to assert any type of "alter ego" or "veil piercing" allegations, the elements of that theory under Florida substantive law should also be consulted. For now, the complaint is insufficiently vague as to the required elements and facts. See generally, Isaiah v. J.P. Morgan Chase Bank, 960 F.3d 1296 (11th Cir. 2020); SE Prop. Holdings, LLC v. Welch, 65 F.4th 1335 1347-49 (11th Cir. 2023).

Id. On July 23, 2024, Plaintiffs filed an Amended Complaint that set forth the following factual allegations, which the Court accepts as true and draws all reasonable inferences from those facts in favor of the non-movant, Plaintiffs.1 On January 10, 2018, Plaintiffs obtained a default judgment in the Eastern District of New York (the “Judgment”) against Biotech Restorations LLC (“Biotech 1”) and Young to the sum of $210,987.50 plus post-judgment interest. Dkt. 27 ¶12. Plaintiffs registered the Judgment in the U.S. District Court for the Middle District of Florida on May 20, 2022. Id. ¶13. On January 5, 2024, Plaintiffs filed a motion to

1 See Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (citing Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555–56 (2007)). The Court need not accept as true any legal conclusions “couched” as facts. Twombly, 550 U.S. at 555 (citing Papasan v. Allain, 478 U.S. 265 (1986)). enforce the Judgment against Young and Biotech 1, and Magistrate Judge Amanda Sansone issued an Order on June 13, 2024, denying Plaintiffs’ motion because

Federal Rule of Civil Procedure 80(a), (e) was the incorrect vehicle to enforce the Judgment. Id. ¶¶14; see Order Denying Motion to Enforce Judgment, No. 8:22-mc- 00018-CEH-AAS (M.D. Fla.) (Document No. 23), filed June 13, 2024.

On or about June 8, 2020, Young allegedly founded Biotech 2 in Florida. Dkt. 27 ¶23. Plaintiffs allege that Young’s position in Biotech 2 is “Founder” or “Chief Technological Officer” based on a screenshot of Biotech 2’s website and a Bradenton Herald newspaper article. Id. ¶¶24-26; Dkts. 27-5 & 27-7. Plaintiffs

contend Biotech 2 is “the ‘reincarnation’ of [Biotech 1], which had been located in Denver, North Carolina, [and] one of the Defendants against whom the default Judgment was entered in favor of Plaintiffs.” Dkt. 27 ¶28. Biotech 2 was allegedly

created “at least in part” for the “purpose of fraudulently transferring the assets and business interests of [Biotech 1] . . . to avoid satisfying the Judgment rendered against [Biotech 1]. . . .” Id. ¶31. Young supposedly transferred assets to Biotech 2 “after the obligation arose against judgment debtors [Biotech 1] and Young.” Id.

¶33. This transfer of assets included “revenues of [Biotech 1] and/or the personal assets of Christopher Young” which indicate “an actual intent to hinder, delay, or defraud judgment creditors . . . and fraudulently avoid payment of the Judgment.”

Id. ¶34. Because, as alleged, the transfer of assets represents a fraudulent transfer under Florida Statute § 726.105(1)(a) and (2), Plaintiffs ask the Court to compel Defendant to remit assets fraudulently received from Young and Biotech 1. Id. ¶¶40,

42. II. DISCUSSION For the reasons discussed below, the Court finds Plaintiffs have pled just

beyond a “formulaic recitation of a cause of action’s elements [that] will not do.” Oginsky v. Paragon Props. of Costa Rica Ltd. Liab. Co., 784 F. Supp. 2d 1353, 1371 (S.D. Fla. 2011) (quoting Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007)). Defendant’s Motion to Dismiss for Failure to State a Claim is denied.

A. Standard of Review Federal Rule of Civil Procedure 8(a) requires a short and plain statement of the claim showing that the plaintiff is entitled to relief in order to give the defendant

fair notice of the claims and grounds. Twombly, 550 U.S. at 555. (citation omitted). The plaintiff is required to allege “more than labels and conclusions, and a formulaic recitation of the elements of a cause of action will not do.” Twombly, 550 U.S. at 555 (citation omitted).

In considering a motion to dismiss, the court must construe the facts in the light most favorable to the Plaintiff. Wiersum v. U.S. Bank, N.A., 785 F.3d 483, 485 (11th Cir. 2015). A complaint “must contain sufficient factual matter, accepted as

true, to state a claim to relief that is plausible on its face” to survive a motion to dismiss. Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (internal quotation marks omitted). “A claim is facially plausible when the court can draw the reasonable

inference that the defendant is liable for the misconduct alleged.” Id. at 662. The standard on a Federal Rule of Civil Procedure 12(b)(6) motion is not whether the plaintiff will ultimately prevail in his claims, but whether the allegations are

sufficient to allow the case to proceed to discovery in an attempt to prove those claims. See Jackam v. Hospital Corp. of Am. Mideast, Ltd., 800 F.2d 1577, 1579 (11th Cir. 1986). B. Plaintiffs have Sufficiently Alleged a Fraudulent Transfer Occurred under FUFTA

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Macro Electronics Corp. v. Biotech Restorations of Florida LLC, Counsel Stack Legal Research, https://law.counselstack.com/opinion/macro-electronics-corp-v-biotech-restorations-of-florida-llc-flmd-2024.